Advertisement

Topics

Prevail Therapeutics, Inc. Company Profile

11:40 EDT 26th April 2018 | BioPortfolio


News Articles [729 Associated News Articles listed on BioPortfolio]

Prevail Therapeutics Grabs $75 Million to Advance Parkinson’s Disease Programs

Seven months after Prevail Therapeutics launched, the company has secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease.

Prevail Therapeutics raises $75m financing for Parkinson's gene therapies

Prevail Therapeutics has secured $75m series A financing to advance the development of gene therapies for patients with Parkinson’s and other neurodegenerative diseases.

Prevail Therapeutics raises $75mm Series A round

Gene therapy start-up Prevail Therapeutics Inc. (neurodegenerative disorders) raised $75mm in a Series A round from OrbiMed (a returning seed investor), Pontifax Fund, RA Capital Management, EcoR1 Cap...

Prevail Therapeutics secures $75m financing to advance development of gene therapies for Parkinson’s disease

Prevail Therapeutics has secured a $75m series A financing to advance the development of gene therapies for patients with Parkinson’s and other neurodegenerative diseases.

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

A potential gene therapy for Parkinson’s disease has just gotten a big boost thanks to one of the larger Series A investment rounds in years for a New York biotech. The funding, for Prevail Therapeu...

Genetics prevail

Prevail adds another genetics-focused neurodegenerative disease play to EcoR1’s portfolio.

Prevail raises $75M series A

Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases

Prevail Therapeutics, Inc. (Prevail), a biotechnology company developing gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases, today announc...

PubMed Articles [432 Associated PubMed Articles listed on BioPortfolio]

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Introduction to Volume 2 of JOPT Special Issue.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [151 Associated Clinical Trials listed on BioPortfolio]

A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.

This prospective, randomized study will evaluate the performance of the Osseotite Certain Prevail implant when compared to that of the non-lateralized version of the implant. Study (null)...

A Study of the Performance of Certain Prevail Implants Used in Short Fixed Cases

This prospective, randomized study evaluates the performance and crestal bone changes difference between the Osseotite Certain Prevail vs the non-lateralized design of the implant. ...

A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.

This prospective, multicenter study evaluates the performance of the Osseotite Prevail implant when to support a short fixed bridge with immediate occlusal loading, providing the patient w...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Peer Mentorship to Reduce Suicide Attempts Among High-Risk Adults

Amid consistently worsening suicide rates, in 2012 the U.S.Surgeon General's National Strategy for Suicide Prevention proposed to "change the narrative" about suicide prevention to include...

Companies [1225 Associated Companies listed on BioPortfolio]

Prevail Therapeutics, Inc.

Pfizer Inc. and Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases....

Bristol-Myers Squibb Company and Gilead Sciences, Inc.

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases....

Bristol-Myers Squibb Company and Simcere Pharmaceutical Group

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases....

Bristol-Myers Squibb Company and Eli Lilly and Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases....

More Information about "Prevail Therapeutics, Inc." on BioPortfolio

We have published hundreds of Prevail Therapeutics, Inc. news stories on BioPortfolio along with dozens of Prevail Therapeutics, Inc. Clinical Trials and PubMed Articles about Prevail Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prevail Therapeutics, Inc. Companies in our database. You can also find out about relevant Prevail Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record